%0 Web Page %A Duggan, Sean %D 2020 %T Osilodrostat: First Approval %U https://adisjournals.figshare.com/articles/online_resource/Osilodrostat_First_Approval/11852751 %R 10.6084/m9.figshare.11852751.v1 %2 https://adisjournals.figshare.com/ndownloader/files/21928275 %K Osilodrostat %K Cushing's disease %K Cushing's syndrome %K Isturisa %K Adis Drug Review %K Adis Insight Report %K 11b-hydroxylase inhibitor %X
Compliance with Ethical Standards
Funding The preparation of this review was not supported by any external funding.
Conflict of interest During the peer review process the manufacturer of the agent under review was offered an opportunity to comment on the article. Changes resulting from any comments received were made by the authors on the basis of scientific completeness and accuracy. Sean Duggan is a salaried employee of Adis International Ltd/Springer Nature, is responsible for the article content and declares no relevant conflicts of interest.
Abstract
© Springer Nature Switzerland AG 2020